Virosomes: Clinical Trials

3 trials of Virosomes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2
Phase 11Completed 1

Follow Virosomes: new trials by email Literature Review of Virosomes trials Research Report on Virosomes

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)
Inflexal V - Influenza
Phase 3CompletedCrucell Holland BV1102013-07-012013-08-30
Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains
Inflexal V - Influenza
Phase 3CompletedCrucell Holland BV1102012-07-012013-12-20
Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania
PEV 301& 302 in virosomes, Inflexal V (active comparator) - Falciparum Malaria
Phase 1CompletedSwiss Tropical & Public Health Institute502008-01-012013-03-15

Conditions studied

Influenza, Human (2)  ·  Virus Diseases (2)  ·  Malaria (1)  ·  Malaria, Falciparum (1)

Sponsors

Crucell Holland BV (2)  ·  Swiss Tropical & Public Health Institute (1)

Countries

Switzerland (2)  ·  Tanzania (1)

Top investigators

Blaise Genton, MD PhD (1)  ·  Michael Seiberling, MD (1)  ·  Milko Radicioni, MD (1)

Results publications

PMID 21799810